Monthly Buprenorphine Shot Clears FDA

Monthly Buprenorphine Shot Clears FDA Monthly Buprenorphine Shot Clears FDA:- The FDA has approved a once-monthly injectable depot formulation of buprenorphine (Sublocade) for moderate-to-severe opioid use disorder patients who’ve been on the sublingual formulation for at least a week, the agency announced. The product can only be dispensed by healthcare […]